JASPER THERAPEUTICS, INC. Noncash or Part Noncash Acquisition, Payables Assumed
JASPER THERAPEUTICS, INC. (JSPR) reported Noncash or Part Noncash Acquisition, Payables Assumed of $16.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2025-11-10
- 2024-09-30: Noncash or Part Noncash Acquisition, Payables Assumed 9 month $16.00K.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 9 month |
|---|---|
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |